Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicinLeonard W Seymour, David R Ferry, David Anderson, et al.Journal of Drug Targeting|May 10, 2007
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligandsFukuto Maruta, Noriyuki Akita, Jun Nakayama, et al.Lancet (London, England)|February 8, 2003
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trialDavid J Kerr, Colin S McArdle, Jonathan Ledermann, et al.International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.Anticancer Research|March 10, 2015
Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trialMegan J McGregor, Wakkas Fadhil, Rose Wharton, et al.Clinical Colorectal Cancer|July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT databaseWinson Y Cheung, Qian Shi, Michael O'Connell, et al.The New England Journal of Medicine|July 27, 2007
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancerDavid J Kerr, Janet A Dunn, Michael J Langman, et al.Molecular Cancer Research : MCR|January 3, 2025
Coevolution of Atypical BRAF and KRAS Mutations in Colorectal TumorigenesisConnor E Woolley, Enric Domingo, Juan Fernandez-Tajes, et al.International Journal of Cancer|April 25, 2022
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndromeKatie Watts, Christopher Wills, Ayman Madi, et al.Pageof 9